A total of 60 papers, reporting 52 unique intervention trials, met eligibility criteria. Before consensus, the level of agreement across all trials between reviewers using the RE-AIM MDIC ranged from 81 to 91 %. The RE-AIM MDIC dimension of ‘efficacy’ had the highest level of reporting, with the five individual items in this dimension reported in 19–100 % of eligible trials (mean 58 %). The RE-AIM MDIC dimension ‘maintenance-setting level’ had the lowest level of reporting, with none of the four individual items in this dimension reported. For other dimensions, the mean level of reporting and range across items were ‘reach’ 34 % (12–60 %); ‘adoption-setting level’ 1 % (0–2 %); ‘adoption-delivery agent level’ 7 % (4–10 %); ‘implementation’ 36 % (13–63 %) and ‘maintenance individual level’ 1 % (0–4 %).